Market News
Stay updated with the latest market trends, earnings, and economic indicators.
CCI clears TVS Group's acquisition of PGIM India AMC, Temasek-Romsons deal
India's fair trade regulator CCI has given the green light for TVS Group entities to acquire PGIM India Asset Management. The regulator also cleared Temasek's investment in medical devices maker Romsons Group. These approvals pave the way for significant business consolidations in the financial and healthcare sectors. The deals involve substantial stake acquisitions and restructuring.
Buy or sell: Gift Nifty trades flat, Vaishali Parekh recommends three stocks to buy today
Buy or sell: Vaishali Parekh recommends three stocks to buy today — Hero MotoCorp, Pine Labs, and M&M Financial Services
Jindal Poly Films dispute, India's first class action suit, sent by Supreme Court to arbitration
The Supreme Court has sent a minority shareholder dispute involving Jindal Poly Films to arbitration. This decision overturns earlier orders from the National Company Law Tribunal and Appellate Tribunal. The case concerns allegations of asset stripping and financial losses to shareholders. The arbitration will take place in Delhi.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Stock Market Crash News Today Live Updates: Nifty Falls Near 23,200, Sensex Declines Over 400 Points; Wockhardt, Schneider Electric Falls 5%
Sectoral indices were mixed in early trade, with Nifty IT rising 2.18% and Nifty Metal gaining 0.13%. On the flipside, Nifty Financial Services fell 1.07%, while Nifty Pharma declined 1.03%.
RBI highlights strong banking sector health, says lenders can withstand severe shocks
In the fiscal year 2025-26, India's financial landscape demonstrated remarkable stability. Both banks and non-bank entities showcased solid balance sheets, reflecting a significant uptick in asset quality and sturdy capital reserves. With gross bad loans hitting their lowest levels in decades, comprehensive stress tests reaffirmed that banks are well-prepared for potential financial adversities.
Buy or sell: Gift Nifty up, Vaishali Parekh recommends three stocks to buy today
Buy or sell: Vaishali Parekh recommends three stocks to buy today — Meesho, Max Financial Services, and GIPCL
Ahead of Market: 10 things that will decide stock market action on Monday
Indian equity benchmarks closed modestly higher on Friday, with financial stocks leading the gains. The Nifty and Sensex edged up, though pharma and healthcare weakness capped the rise. Analysts noted the market's indecisive range-bound movement, awaiting a decisive breakout above 23,800 for further upward momentum or a fall towards 23,600.
Nifty could hit 27,000 once geopolitical tensions ease: Bajaj Finserv AMC CIO
Bajaj Finserv AMC CIO Nimesh Chandan projects 15% earnings growth for Nifty in FY28, with EPS rising to the ₹1,420–1,440 range, making valuations look attractive. He backs metals, construction, and cement as long-term plays on a global supply chain shift, holds gold and silver in the multi-asset portfolio, and flags El Niño and elevated US yields as key risks keeping Indian interest rates high in the near term.